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24 hours ambulatory blood pressure monitoring (ABPM).
We identified patients with known hypertension, masked hypertension and
white-coat effect.  
 
Results: 
 
258 HIV+ patients (mean age
 
 
 
49 ± 7 ans, 91% men)
 
 
 
were consec-
utively included in this study between 2005 and 2009. Cardiovascular risk fac-
tors were as follows: 52% had dyslipidemia, 51% were active smokers, 40%
with known hypertension and 9 % were diabetics. Body mass index of the
entire cohort was 24 ± 4 kg/m
 
∑
 
 and 89% were under antiretrovirals. Data on
blood pressure are depicted in Table 1. 19% (29) were discovered to have
hypertension. 
 
Conclusion: 
 
Hypertension is frequent in HIV-infected patients and more
and more common with aging. The number of non-dipper HIV+ was high in
this cohort. Studies on the impact of HIV infection and antiretrovirals on the
autonomic nervous system should be performed.  
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Background:
 
 Abdominal aortic aneurysm (AAA) remains asymptomatic
for many years but often revealed dramatically (inaugural rupture). Its rela-
tively low prevalence in the general population (5.5% of men over 65 years)
implies specific target population screening. Patients with acute myocardial
infarction (AMI) represent a high-risk population in which screening for other
atherosclerotic locations is recommended but is still often neglected. We
aimed to evaluate the feasibility of AAA screening during routine transtho-
racic echocardiography (TTE) in patients with AMI using a portable echocar-
diography system and to determine the prevalence of AAA in this population. 
 
Methods:
 
 We prospectively measured the size of the abdominal aorta at
the end of a regular TTE performed at bedside in consecutive patients
admitted for AMI in our intensive care unit using a portable TTE system
(Vividi, General electric). AAA was defined by a transverse diameter  30 mm. 
 
Results:
 
 One hundred and fifty two patients were enrolled (mean age
65±14 years old, 78% of male). Measurement of the size of the abdominal
aorta was feasible in 93% (10 patients had poor echogenicity) and time dura-
tion was 3±1min. Interobserver variability between cardiologists was good
(1.7±1mm). Eight patients had an AAA (5.2%) and prevalence increases with
age, 8.7 % after 60 years, 10.3% after 65 years. No patient below 50 years old
had an AAA.
 
Conclusion:
 
 In patients admitted for AMI, screening for AAA during TTE
using a portable TTE system was fast and highly feasible. Despite a striking
low prevalence of AAA in this high cardiovascular risk population, analyse of
the abdominal aorta should be recommended during TTE ("one cardiovascular
shot") especially in elderly patients in regard to the simplicity, inocuity and
availability of the present screening.
 
230
 
Prevalence and risk factors of lower extremity artery disease in sub-
jects without traditional modifiable cardiovascular risk factors. The
multi-ethnic study of atherosclerosis.
Victor Aboyans (1), Robyn L. Mcclelland (2), Matthew A. Allison (3),
Mary M Mcdermott (4), Roger S. Blumenthal (5), Katarzyna Macura (6),
Michael H. Criqui (3)
(1) Hôpital Dupuytren, CHU Limoges, Service de CTCV & Angiologie,
Limoges, France - (2) University of Washington, Seattle, Department of
Biostatistics, Seattle, Etats-Unis - (3) University of California, San Diego,
Dept. of Family and Preventive Medicine, San Diego, Etats-Unis - (4)
Northwestern University Feinberg School of Medicine, Chicago, Chicago,
Etats-Unis - (5) Johns Hopkins Ciccarone Center for Prevention of Heart
Disease, Baltimore, Etats-Unis - (6) Dept. of Radiology, Johns Hopkins
University, Baltimore, Etats-Unis
Introduction: 
 
Lower-extremity peripheral artery disease (PAD) is associ-
ated with traditional cardiovascular disease risk factors (smoking, hyperten-
sion, dyslipidemia, diabetes). Among participants in the Multi-Ethnic Study of
Atherosclerosis (MESA), we sought to assess the prevalence of PAD in a pop-
ulation without these risk factors. We hypothesized that this prevalence is not
negligible, and that in this situation, PAD would still remain associated with
other measures of subclinical atherosclerosis.
 
Methods:
 
 In the MESA cohort, we selected those (n=1932) meeting the
following criteria: no smoking over the last 10 years, no history of hyperten-
sion, dyslipidemia or diabetes, and normal blood pressure (140/90), fasting
blood glucose 1.26 g/l, and a total-/HDL-cholesterol ratio <5. Participants
were classified according to their ankle-brachial index (ABI) into 3 groups:
low (<1.00), normal (1.00-1.30) and high (>1.30) ABI. Measures of subclin-
ical atherosclerosis included any coronary artery calcification (CAC) or carotid
plaque.
 
Results:
 
 Overall, the mean estimated Framingham risk score for coronary
heart disease was 0.61% /year. Low- and high ABI were found in 176 (9%)
and 149 (7.8%) participants, respectively. In multivariable models including
age, gender and ethnicity, lower glomerular filtration rates (OR: 0.88 /10 units,
p=0.04) and higher interleukin-6 levels (OR:1.42 /natural-log unit, p=0.02)
were associated with low ABI. Higher body-mass index (OR:1.07 /unit,
p<0.001) was associated with high ABI. In a fully-adjusted model, low-ABI,
not high-ABI, was significantly associated with CAC prevalence (OR:1.22,
p<0.03). No significant association was found with carotid plaque.
 
Conclusion:
 
 In subjects without traditional risk factors, PAD is common.
Such persons remain at higher risk for coronary artery disease.
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Background
 
: Ambulatory blood pressure monitoring (ABPM), while used
routinely in Hypertension, has rarely been applied in Chronic Heart Failure
(CHF). This study was designed to assess prognostic value of ABPM data in
our patients with CHF.
Parameters N= 258
Office systolic BP, mmHg 131 ± 19
Office diastolic BP, mmHg 81 ± 10
Mean 24h-systolic BP, mmHg 125 ±13
Mean 24-diastolic BP, mmHg 77 ± 9
Daytime systolic BP, mmHg 129 ± 13
Daytime diastolic BP, mmHg 80 ± 9
Nighttime systolic BP, mmHg 115 ± 17
Nighttime diastolic BP, mmHg 68 ±10
BP profile in known hypertensive patients N= 103
Number of patients with appropriate BP control, % 45%
Number of patients with white-coat effect, % 17%
Non dipper, % 43% in known 
hypertensive patients 
39% in unknown 
hypertensive patients 
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Methods and Results:
 
 In this preliminary work, a retrospective analysis on
288 patients (227 men (79%), 61 women (21%)) who had received an ABPM in
our Heart Failure unit between 1999 and 2006 was made. Our study population,
with a mean age of 59.6 years consists of 45.2% ischemic cardiomyopathy, 42.6
% idiopathic dilated cardiomyopathy, 9.3 % hypertrophic cardiomyopathy, 2.9
% valvular cardiomyopathy. Almost all are symptomatic (NYHA I (8.3%) II
(48.2%) III (37.8%) IV (5.5%)) and average ejection fraction (EF) is 28.2%.
ABPM data and patient characteristics are studied in bivariate analysis: EF cor-
related positively with mean pulse pressure (PP) (daytime PP: r=0.47,p<0.001,
nightime PP: r=0.44,p<0.001), mean 24h-systolic blood pressure (SBP)(daytime
SBP: r=0.39, p<0.0001, nightime SBP:r=0.33, p<0.001) but no significance with
dipper status (p>0.05). Significative difference found for 24 h-PP (p<0.02),
dipper status between diabetic (n=60/288) and no diabetics patients. Creatinine
blood level correlated negatively with dipper status (r=-0.2, p<0.001). As regard
NYHA class, only one significative negative correlation exists with mean day-
time-SBP but not with PP or dipper status. 
 
Conclusions:
 
 Preliminary results of this study appear to be consistent with
medical knowledges. Our prospective study of survival, currently underway in
these patients, will allow us to identify prognosis interest of ABPM in CHF.
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Background: 
 
Guidelines recommend low molecular weight heparin
(LMWH) and fondaparinux (fonda) over unfractionated heparin (UFH) for ini-
tial treatment of acute pulmonary embolism (PE), except in patients (pts) at
high risk of bleeding & with severe renal dysfunction. No trial has assessed
the comparative efficacy of enoxaparin (enox) and fonda in this setting. 
 
Methods: 
 
Prospective, multicenter registry. Pts with proven recent PE
(symptom onset <15 days), treated with approved regimens of enox or fonda
were included. Pts with high risk PE, and those with recent or active bleeding,
recent surgery or stroke, or renal failure were excluded. We calculated a pro-
pensity score by logistic regression (i.e. predicted probability of treatment by
enox as opposed to fonda). Combined in-hospital endpoint was defined as
death, recurrent PE or major bleeding. Secondary endpoints were residual pul-
monary vascular obstruction (RPVO) at discharge and 6m, and 6m mortality. 
 
Results: 
 
Of 501 pts included between 2006 and 2010, 229(46%) received
enox and 272 (54%) received fonda. 5(2.2%) pts under enox had recurrent PE
vs 5 (1.8%) fonda pts (p=0.96). 13(5.7%) enox pts and 9(3.3%) fonda pts had
major bleeding (p=0.19), in-hospital mortality was 3.5% and 1.1% respec-
tively (p=0.07). During in-hospital stay, 19(8.3%) of pts treated with enox
reached at least 1 clinical endpoint vs 12(4.4%) fonda pts (p=0.07). After
adjusting on propensity score, there was no significant difference in death,
recurrent PE, major bleeding or combined endpoint (enox vs fonda, OR=1.45
[0.67-3.14]). RPVO at discharge was 28.4±14.6% in enox vs 27.2±13.9 in
fonda pts (p=0.57). There was no difference in RPVO at 6m. The 6m mortality
rate was 8.5% in enox pts vs 9.3% in fonda pts (p=0.76).
 
Conclusion: 
 
Our results suggest that enox and fonda can be used inter-
changeably, as efficacy and safety profiles are comparable in non-high risk
acute PE patients. Neither molecule appears to induce an excess bleeding risk
as compared to the other.
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Background:
 
 After an acute coronary syndrome (ACS), pharmacologic
therapy and lifestyle intervention (optimal medical therapy, OMT) are efficient
in reducing cardiovascular (CV) events. However, even if recommended sec-
ondary prevention goals are reached, a subset of patients still present CV
events.
 
Aim:
 
 To identify biological or cardiovascular markers predicting the
residual risk of CV events in post-ACS patients receiving OMT.
 
Patients and methods:
 
 990 patients benefited from an evaluation of risk
factors and atherosclerosis lesions, and optimization of long-term treatment
and education. Traditional CV risk factors and atheroma disease markers
(intima-media thickness (IMT), carotid atheroma, Ankle Brachial Index (ABI)
and number of coronary arteries with >50% stenosis) were evaluated 3 months
after ACS. CV events were recorded at follow-up (CV death, ACS, stroke,
heart failure, revascularization).
 
Results:
 
 At a median follow-up of 20 months, more than 80% of the
patients reached recommended prevention goals. 116 total CV events were
recorded. Diabetes was the only CV risk factor significantly associated with
CV events in multivariate analysis (including age, sex, hypertension, LDL
cholesterol, smoking, diabetes and hsCRP); HR 1,61 (1,09-2,39), p=0,017. In
multivariate analysis including CV risk factors and atheroma disease markers
(peripheral vascular disease (PVD) defined as ABI<0,9, carotid plaque > 50%,
IMT >0,7mm, 3-vessel and/or left main coronary disease), only PVD remained
significantly associated with CV events; HR 1,83 (1,02-3,31), p=0,04. The
number of vascular beds involved was associated with poorer prognosis: HR
for 3 vascular-beds disease 3,85 (1,72-8,63) p=0,001, given 1 vascular-bed
disease as a reference group.
 
Conclusion:
 
 In post-ACS patients with OMT, PVD and atheroma burden
represent powerful prognostic markers of CV events, while diabetes remains
the only independent marker of CV events among traditional CV risk factors. 
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Objectives: 
 
Cigarette smoking induces cardiovascular pathology and
worsens arterial stiffness. Arterial stiffness can be assessed non-invasively on
2 indices: pulse-wave velocity (PWV), indicating aortic stiffness, and augmen-
tation index (AIx), indicating aortic wave reflection. The impact of smoking
cessation (SC) nicotine replacement therapies (NRT) on arterial stiffness
remains unknown.
 
Methods: 
 
AIx and PWV were studied prospectively (SphygmoCor) in 26
long-term smokers (>10 cigarettes/day; mean age, 43±6 yrs) before (V1) and
28 and 56 days (V2,V3) after SC supported by NRT. Two-way repeated-mea-
sures ANOVA was used with patients serving their own controls on intention-
to-treat analysis. Abstinence was ascertained when exhaled carbon monoxide
(CO) was <10ppm; the quantity of NRT absorbed was assessed from the
serum cotinine level.
 
Results: 
 
16/24 patients (67%) were abstinent at end of study; 8/24 had
cut down on smoking; 2 were lost to follow-up. CO and serum cotinine
levels fell after SC. Mean AIx for the population as a whole was 23.4% at
V1, with significant early reduction by V2 (16.2%) and V3 (13.9%)
(ANOVA p<0.001). PWV, peripheral blood pressure and heart rate were
unchanged. Multivariate analysis failed to identify predictive factors among
baseline characteristics, cigarette addiction levels, or evolution of expired
CO or serum cotinine.
 
 
Conclusions: 
 
The improvement in
 
 
 
AIx and stability of PWV after SC with
NRT indicate improved peripheral vascular tone. This impact may account for
the early clinical benefit of SC observed even when associated to NRT.
